StuartHCohenMD
Infectious Disease • Sacramento, CAProfessor, Internal Medicine, UC, Davis School of Medicine
Dr. Cohen is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4150 V St
# G500
Sacramento, CA 95817Phone+1 916-734-3741Fax+1 916-734-7766
Education & Training
University of California Davis HealthFellowship, Infectious Disease, 1981 - 1983
University of New Mexico School of MedicineResidency, Internal Medicine, 1978 - 1981
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 1978
Certifications & Licensure
CA State Medical License 1981 - 2027
NM State Medical License 1979 - 1992
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI) Start of enrollment: 2015 May 01
- Decolonization to Reduce After-Surgery Events of Surgical Site Infection Start of enrollment: 2023 Jan 17
Roles: Principal Investigator, Study Director, Contact
Publications & Presentations
PubMed
- Risk factors for the development ofinfection in patients colonized with toxigenic.Josh Clement, Gauri Barlingay, Sindhu Addepalli, Heejung Bang, Monica A Donnelley
Infection Control and Hospital Epidemiology. 2025-02-24 - Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.Colleen S Kraft, Matthew Sims, Michael Silverman, Thomas J Louie, Paul Feuerstadt
Infectious Diseases and Therapy. 2024-10-01 - Correction to: Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.Colleen S Kraft, Matthew Sims, Michael Silverman, Thomas J Louie, Paul Feuerstadt
Infectious Diseases and Therapy. 2024-10-01
Press Mentions
Five Years Ago, WHO Declared a Global Pandemic. Where Things StandMarch 12th, 2025- UC Davis Health Launches New Invasive E. Coli Disease Vaccine TrialMay 16th, 2023
- How a More Nutritious Diet Can Help Combat Long COVIDMarch 14th, 2023
- Join now to see all
Grant Support
- The DECREASE SSI Trial (Decolonization to Reduce After-Surgery Events of Surgical Site Infection)UNIVERSITY OF CALIFORNIA-IRVINE2022–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
